Stock CCEL CRYO-CELL INTERNATIONAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Cryo-Cell International, Inc.

Equities

CCEL

US2288951088

Healthcare Facilities & Services

Real-time Estimate Cboe BZX
Other stock markets
 07:16:20 14/05/2024 pm IST 		5-day change 1st Jan Change
9.07 USD +1.45% Intraday chart for Cryo-Cell International, Inc. +3.59% +55.48%
15/04 Cryo-Cell International, Inc. Reports Earnings Results for the First Quarter Ended February 29, 2024 CI
25/03 Cryo-Cell International to Spin Off Celle Unit, Explore Strategic Alternatives; Shares Jump MT

Valuation

Fiscal Period: November 2020 2021 2022 2023 2024 2025
Capitalization 1 56.59 105.6 37.23 44.33 72.45 -
Enterprise Value (EV) 1 56.59 105.6 37.23 44.33 72.45 72.45
P/E ratio 16.7 x 49.5 x 13.2 x -4.69 x 298 x 74.5 x
Yield - - - - - -
Capitalization / Revenue - - 1.23 x 1.41 x 2.28 x 2.06 x
EV / Revenue - - 1.23 x 1.41 x 2.28 x 2.06 x
EV / EBITDA - - 6.16 x - 22.5 x 14.8 x
EV / FCF - - - - - -
FCF Yield - - - - - -
Price to Book - - - - - -
Nbr of stocks (in thousands) 7,546 8,530 8,519 8,287 8,104 -
Reference price 2 7.500 12.38 4.370 5.350 8.940 8.940
Announcement Date 01/03/21 22/02/22 28/02/23 28/02/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: November 2020 2021 2022 2023 2024 2025
Net sales 1 - - 30.34 31.34 31.78 35.21
EBITDA 1 - - 6.041 - 3.225 4.882
EBIT 1 - - 4.024 -12.3 2.377 4.256
Operating Margin - - 13.27% -39.26% 7.48% 12.09%
Earnings before Tax (EBT) 1 - - 3.319 -13.36 0.353 1.45
Net income 1 3.625 2.084 2.771 -9.522 0.239 1.044
Net margin - - 9.14% -30.38% 0.75% 2.96%
EPS 2 0.4500 0.2500 0.3300 -1.140 0.0300 0.1200
Free Cash Flow - - - - - -
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 01/03/21 22/02/22 28/02/23 28/02/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: November 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 - 7.7 7.764 7.82 7.773 7.87 7.877 7.852 7.954 8.026 7.944 7.952 8.132
EBITDA 1 - 1.236 1.011 1.888 1.332 1.565 - 0.9021 1.026 0.507 0.482 1.145 1.073
EBIT 1 - 0.9543 0.4054 1.683 1.028 1.161 -16.18 0.8212 0.873 0.354 0.329 0.988 0.917
Operating Margin - 12.39% 5.22% 21.52% 13.22% 14.75% -205.37% 10.46% 10.98% 4.41% 4.14% 12.42% 11.28%
Earnings before Tax (EBT) 1 - 0.641 0.6225 1.215 0.3464 1.068 -15.99 0.7945 0.409 -0.413 -0.438 0.221 0.237
Net income 1 0.6347 0.4668 0.8378 0.767 0.221 0.6806 -11.19 0.5562 0.295 -0.297 -0.315 0.159 0.171
Net margin - 6.06% 10.79% 9.81% 2.84% 8.65% -142.06% 7.08% 3.71% -3.7% -3.97% 2% 2.1%
EPS 2 0.0700 0.0600 0.1000 0.0900 0.0300 0.0800 -1.340 0.0700 0.0400 -0.0400 -0.0400 0.0200 0.0200
Dividend per Share - - - - - - - - - - - - -
Announcement Date 11/07/22 14/10/22 28/02/23 21/04/23 14/07/23 12/10/23 28/02/24 15/04/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: November 2020 2021 2022 2023 2024 2025
Net Debt - - - - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - - - - - -
ROE (net income / shareholders' equity) - - - - - -
ROA (Net income/ Total Assets) - - - - - -
Assets 1 - - - - - -
Book Value Per Share - - - - - -
Cash Flow per Share - - - - - -
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 01/03/21 22/02/22 28/02/23 28/02/24 - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Cryo-Cell International, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
8.94 USD
Average target price
9 USD
Spread / Average Target
+0.67%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
CRYO-CELL INTERNATIONAL, INC. Stock Cryo-Cell International, Inc.
+55.48% 7.25Cr
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+17.50% 8.31TCr
CVS HEALTH CORPORATION Stock CVS Health Corporation
-27.87% 7.09TCr
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+3.59% 2.83TCr
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-6.82% 1.77TCr
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
+2.10% 1.74TCr
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+2.25% 1.56TCr
REDE D'OR SÃO LUIZ S.A. Stock Rede D'Or São Luiz S.A.
+8.17% 1.35TCr
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
+7.53% 1.28TCr
NATERA, INC. Stock Natera, Inc.
+67.39% 1.27TCr
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. CCEL Stock
  4. Financials Cryo-Cell International, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW